Trial of MiStent Compared to Xience in Japan

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

Also called NCT02972671

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02972671
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02972671. Randomized; double masking; primary purpose treatment. Start 2016-11-28 (actual); primary completion 2018-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Trial of MiStent Compared to Xience in Japan
Acronym
DESSOLVEJ
Condition
Coronary (Artery); Disease
Intervention (Device)
MiStent (MT005) Coronary Artery Stent
Intervention (Device)
Xience Coronary Artery Stent
Lead sponsor
Micell Technologies (class: industry)
Collaborator
Cardialysis BV (class: industry)
Collaborator
ClinLogix. LLC (class: industry)

Record details

Record id
cardio:ct-nct02972671
Content hash
52bf211f4de9a03b3c427e39db59b0c13cafffe5e445231210b235ea810a502a